PMC8128506_01
Facial transformation in a 40-year-old male-to-female transgender patient who received onabotulinumtoxinA and dermal fillers to feminize the face. Photographs were taken 2 months post-treatment. Patient images provided by Alexander Rivkin, MD.
CCID-14-513-g0002.jpg
PMC8128506_01_CCID-14-513-g0002.jpg
f0002
Facial transformation in a 40-year-old male-to-female transgender patient (Figure 2).
PMC8128506_02
Full-face transition of a 25-year-old male-to-female transgender patient who received onabotulinumtoxinA and dermal fillers to feminize the face. (A) Colored dots and arrows indicate injection points with corresponding concentrations of onabotulinumtoxinA or filler injected. (B) The patient before (left) and 3 months after (right) treatment. Patient images provided by Vincent Wong, MD.
CCID-14-513-g0003.jpg
PMC8128506_02_CCID-14-513-g0003.jpg
f0003
Full-face transition in a 25-year-old male-to-female transgender patient (Figure 3).
PMC8128506_03
Masculinization of the jawline with repeated VYC-20L injections in a 42-year-old female-to-male transgender patient. (A) Colored dots and arrows indicate injection points with corresponding concentrations of filler injected. (B) The patient before (left) and 4 months after (right) treatment. Patient images provided by Koenraad De Boulle, MD.
CCID-14-513-g0004.jpg
PMC8128506_03_CCID-14-513-g0004.jpg
f0004
Masculinization of the jawline in a 42-year-old female-to-male transgender patient (Figure 4).
PMC8128506_04
Female-to-male jawline and chin enhancement in a 19-year-old patient who received VYC-25L. (A) Colored dots and arrows indicate injection sites with corresponding concentrations of filler injected. (B) The patient before (top) and immediately after (bottom) treatment. Photographs were taken immediately following treatment. Patient images provided by Vincent Wong, MD.
CCID-14-513-g0005.jpg
PMC8128506_04_CCID-14-513-g0005.jpg
f0005
Female-to-male jawline and chin enhancement in a 19-year-old patient (Figure 5).
Feminization of the eyebrow using onabotulinumtoxinA in a patient in his late 20s. The patient before (left) and 2 weeks after (right) treatment. Patient images provided by Terrence Keaney, MD.
CCID-14-513-g0006.jpg
PMC8128506_04_CCID-14-513-g0006.jpg
f0006
Feminization of the eyebrow using onabotulinumtoxinA in a patient in his late 20s (Figure 6).
Feminization of the lips using HYC-24L in a patient in his early 60s. The patient before (left) and 2 weeks after (right) treatment. Patient images provided by Terrence Keaney, MD.
CCID-14-513-g0007.jpg
PMC8128506_04_CCID-14-513-g0007.jpg
f0007
Feminization of the lips using HYC-24L in a patient in his early 60s (Figure 7).